The CDC released some changes to the recommended immunization schedule in early February of 2016. Here’s what you need to know:
Meningococcal B Disease
The Meningococcal B vaccine was approved by the Food and Drug administration in 2014. This was in response to outbreaks in colleges around the U.S. Meningococcal B (a cause of Menigitis) is a very rare disease, but when caught can be life-threatening. In fact, about 10-15 out of 100 people who catch Men B are killed, and many survivors will develop disabilities. The introduction of the vaccine has helped reduce cases.
What Changed?
The CDC’s immune schedule CDC’s immunization schedule is now suggesting the Men B vaccine at age 16 years with a booster one month later. Menactra (which protects against other strains of the meningococcal bacteria) is still recommended at age 11-12 years with a booster at age 16 years.
For more information on all vaccines, visit http://www.immunize.org/vis/
